Atlas Trials

Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer

Clinical trial NCT04922853 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04922853
Sponsor
West China Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Rectal CancerNeoadjuvant Chemotherapy
Start date
2021-08-26
Primary completion
2024-10-01
Enrollment
554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.